The Bombay High Court has asked the Maharashtra Food and Drug Administration (FDA) to use its powers judiciously after Cadila Pharmaceuticals Ltd challenged the regulator’s decision to stop the sale of some of its medicines. The court questioned the FDA’s approach and accepted its assurance that the orders against Cadila would be revoked, followed by show-cause notices and a hearing, a TOI report stated.
